AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
13min chapter
Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson
Blood Cancer Talks
Biospecific Antibodies in Treating Refractory Lymphoma
This chapter discusses the potential of biospecific antibodies in treating lymphoma patients who have not responded to CAR T cell therapy. The speakers highlight the advantages and challenges of using biospecific antibodies, comparing response rates and durability of complete remission with CAR T cell therapy. They also discuss the need for larger trials and long-term follow-up to gather more data on the efficacy of biospecific antibodies.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode